// App-Quantinova.ai

P-102 : Progesterone luteal-phase support during IUI cycle should be added depending on women age and/or on previous mid-luteal progesterone assessment to promote live births

Researchers

Presenter

  • C.H Petrovic

Principal Investigators

  • M Benchaib

  • C Monnier

  • M Kavanagh

  • M Leflon

  • S Asif

  • D Gardner

  • N Keates

  • J. Hernandez Medrano

  • M Tomlison

  • A Torre

Medical Centers

  • University of Nottingham Medical School, School of Life Sciences, Nottingham, United Kingdom

  • Université Lyon 1 - Hospices Civil de Lyon, Laboratoire de Biologie de la Reproduction-CECOS, Lyon, France

  • School of Veterinary Medicine and Science - Nottingham University, Department of Diagnostics and Therapeutics, Nottingham, United Kingdom

  • Université de Normandie-Centre Hospitalier Universitaire de Rouen, Department of Gynecology and Obstetrics, Rouen, France

  • Centre Hospitalier du Sud Francilien, Service de Gynécologie Obstétrique - Centre de Procréation Médicalement Assistée, Corbeil-Essonnes, France

  • Faculty of Veterinary Medicine - University of Calgary- Canada, Department of Production Animal Health, Calgary, Canada

  • Nottingham University Hospital - Nottingham NHS Trust-, Fertility unit, Nottingham, United Kingdom

Locations

  • United Kingdom

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Infertility

  • Polycystic Ovary Syndrome

Biomarkers

  • Progesterone

Drug/Treatment

  • clomiphene

  • CycloGest

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved